Valeriandoid B

Catalog No. :
ACCXGF814
CAS No. :
1380399-57-4
Molecular Formula :
C24H33ClO10
Molecular Weight :
516.97

IUPAC Name:(1S,6S,7S,7aS)-4-(acetoxymethyl)-7-(chloromethyl)-7-hydroxy-1-((3-methylbutanoyl)oxy)-1,6,7,7a-tetrahydrocyclopenta[c]pyran-6-yl 3-acetoxy-3-methylbutanoate

Valeriandoid B structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$370.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameValeriandoid B
IUPAC Name(1S,6S,7S,7aS)-4-(acetoxymethyl)-7-(chloromethyl)-7-hydroxy-1-((3-methylbutanoyl)oxy)-1,6,7,7a-tetrahydrocyclopenta[c]pyran-6-yl 3-acetoxy-3-methylbutanoate
Molecular FormulaC24H33ClO10
Molecular Weight516.97
SMILESCC(C)(OC(C)=O)CC(O[C@H]([C@@]1(CCl)O)C=C2[C@]1([H])[C@H](OC(CC(C)C)=O)OC=C2COC(C)=O)=O
InChI KeyLPWTVFWINSHGLS-STCFVSJZSA-N
SynonymValeriandoid B;Chlorovaltrate M;Butanoic acid, 3-(acetyloxy)-3-methyl-, (1S,6S,7S,7aS)-4-[(acetyloxy)methyl]-7-(chloromethyl)-1,6,7,7a-tetrahydro-7-hydroxy-1-(3-methyl-1-oxobutoxy)cyclopenta[c]pyran-6-yl ester;ChlorovaltrateM/ValeriandoidB
CAS No.1380399-57-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACCXGF814 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCXGF814 route product structure diagram
    ACCXGF8141380399-57-4
Inquiry

2. ACCXGF814 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCXGF814 route product structure diagram
    ACCXGF8141380399-57-4
Inquiry

Comments (0)